It was time for a change
Copake, NY (PRWEB) July 21, 2009
Bioremedi Therapeutic Systems Inc. announces the latest upgrade to the HealthLight infrared phototherapy system, sometimes erroneously referred to as Anodyne Therapy. Not content to wait for the market to devise a better and more efficient LED for its current, industry leading devices, Bioremedi Therapeutic Systems Inc worked closely with engineers over the past six months to develop a new LED that was more energy efficient and emitted greater power than the version used for the past 10 years. "It was time for a change," said Patrick Doyle, president of Bioremedi Therapeutic Systems Inc, "and, as industry leaders, it was our responsibility to drive this improvement."
According to recent laboratory tests, the new Irvisium Superflux 880 emits 17.1Mw/cm2 per diode, which is more than triple the previous LEDs power rating of 5.1Mw/cm2 and 8 times greater than the LED deployed in Anodyne Therapy 8 pad Pro Clinical or home devices. See video here: http://www.youtube.com/watch?v=7cSJRapjA0s
"What this means to health care professionals is better outcomes in less time," says Dr. Thomas Burke, medical director for Bioremedi Therapeutic Systems Inc. "Busy clinical practices will be able to offer more treatments per day and that translates directly into greater revenue streams for clinics."
Even with the significant increase in output power, laboratory-testing shows only a 1ºF increase in temperature. This is directly attributable to the increased energy efficiency of the new LED and enhanced voltage control in the base units. As little as a 1% drift in voltage can create a 3% rise in temperature, which could lead to patient burns. This problem has plagued other manufacturers for years and remains an ongoing problem for them.
Dave Melone, chief engineer for the HealthLight product, projects a 100% incorporation of the Irvisium Superflux 880 (infrared diode) and the Irvisium Superflux 650 (red diode) by mid August of this year in all HealthLight devices.
In May 2009 the company launched its new MiniPro controller in anticipation of the new LEDs becoming available. Combining the MiniPro with the Irvisium Superlfex LED pad accessories allows practitioners to reduce their financial investment by as much as 50% while increasing their treatment capability in the clinic, office or in the field.
According to Doyle "The importance of interoperability with HealthLight's legacy equipment was paramount and compatibility with all existing pad accessories was mandatory when we designed the Mini-Pro controller. It blends the simplicity of the portable model with the functionality of the clinical model."
Bioremedi Therapeutic Systems Inc. is the manufacturer of HealthLight http://healthlight.us/ pulsed infrared devices used primarily for reducing the pain and inflammation often associated with neuropathy from diabetes or other causes.